Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Ocugen Inc (NQ: OCGN )

0.9493 +0.0383 (+4.20%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen Inc

< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Here's Why Ocugen Stock Rocketed 47% Today -- and Then Gave Up Almost All Its Gains
The biotech is seeking to cash in on the recent rally in its stock price. 
Via The Motley Fool
Exposures COVID-19
Ocugen Looks Less Interesting With Each Passing Shot
OCGN stock popped in February as investors anticipated revenue from a Covid-19 vaccine partnership. But the U.S. looks to be well supplied. 
Via InvestorPlace
Exposures COVID-19
32 Stocks Moving In Friday's Mid-Day Session
Gainers Sypris Solutions, Inc. (NASDAQ: SYPR) shares climbed 24.7% to $3.50 after the company said its electronics unit has won a contract for deep space program. MicroVision,... 
Via Benzinga
Ocugen Stock Relief Pop Is Great, But It Needs More
OCGN stock soared on great news but it is now going into a prior failure level. Investors can hold it long term but short term, it's tricky. 
Via InvestorPlace
Here's Why Snap And Ocugen Are Popping Off Today
Snap Inc (NYSE:SNAP) shares are trading higher by 4.5% in Friday’s pre-market ... 
Via Benzinga
OCGN Stock: The Big COVAXIN News That Prompted 40% Gains in Ocugen
OCGN stock is seeing upward momentum as it looks to become just the fourth vaccine option available in the U.S. 
Via InvestorPlace
Exposures COVID-19
Global Market For Sleep Aid Devices Could Reach $112.7 Billion By 2025
Via FinancialNewsMedia
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Jaguar Health (NASDAQ:JAGX) shares moved upwards by 11.8% to $1.61 during Friday's pre-market session. The market value of their outstanding shares is at $205.... 
Via Benzinga
25 Stocks Moving in Friday's Pre-Market Session
Gainers Sypris Solutions, Inc. (NASDAQ: SYPR) shares rose 42% to $3.99 in pre-market trading after the company said its electronics unit has won a contract for deep space program... 
Via Benzinga
Is It Too Late to Buy Ocugen Stock?
The shares have soared on good news from its potential coronavirus vaccine. 
Via The Motley Fool
Exposures COVID-19
44 Biggest Movers From Yesterday
Gainers KnowBe4, Inc. (NASDAQ: KNBE) shares jumped 50.9% to close at $24.14 on Thursday after the company priced its IPO at $16 per share. Neuropace, Inc. (NASDAQ: NPCE) shares... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Johnson & Johnson COVID-19 Vaccine Could Make Its Way To India By July
Johnson & Johnson’s (NYSE: JNJ) single-shot COVID-19 vaccine is expected to be imported to India for the fill and finish process over the next two to three months,... 
Via Benzinga
Exposures COVID-19
Why Ocugen Shares Skyrocketed Today
Ocugen Inc (NASDAQ: OCGN) shares soared 42.9% in the regular session and another 11% in the after-hours session on Thursday. What Happened: The shares surged following positive... 
Via Benzinga
Here's Why Ocugen Stock Skyrocketed Today
Analysts are growing more optimistic about the coronavirus vaccine maker's growth prospects. 
Via The Motley Fool
Exposures COVID-19
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Ocugen (NASDAQ:OCGN) stock moved upwards by 7.1% to $9.95 during Thursday's after-market session. At the close, Ocugen's trading volume reached 7.6 million shares... 
Via Benzinga
Why Ocugen and Nikola Are Powering the Nasdaq Higher
Favorable news from two key sectors helped support the broader market. 
Via The Motley Fool
Topics Electric Vehicles Stocks
Exposures Electric Vehicles US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Renalytix AI (NASDAQ:RNLX) shares rose 21.41% to $30.62 during Thursday's regular session. Renalytix AI's stock is trading at a volume of 1.0 million... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ocugen Partner Reports Strong Phase 3 Results for Coronavirus Vaccine
Bharat Biotech says that its Covaxin demonstrated 100% efficacy against severe COVID-19. 
Via The Motley Fool
Exposures COVID-19
Could This Little-Known Company's Vaccine Candidate Leapfrog Moderna and Pfizer?
This small-cap biotech is currently trailing its rivals in the coronavirus vaccine race. Could a comeback be in the cards? 
Via The Motley Fool
Exposures COVID-19
48 Biggest Movers From Yesterday
Gainers Welbilt, Inc. (NYSE: WBT) shares surged 44.5% to close at $22.58 on Wednesday after The Middleby Corporation announced plans to acquire the company. Skillz Inc. (NYSE:... 
Via Benzinga
Why Ocugen Stock Surged Today
The biotech announced positive data for the coronavirus vaccine candidate it hopes to bring to the U.S. market. 
Via The Motley Fool
Exposures COVID-19
2 Biopharma Stocks That Look Ready For A Bullish Reversal
Ocugen Inc. (NASDAQ: OCGN) and Bionano Inc. (NASDAQ: BNGO) are two biopharma stocks moving higher Wednesday. Ocugen is moving after its partner Bharat Biotech announced... 
Via Benzinga
Why Bionano Genomics, Ocugen Are Rallying Today
Bionano Genomics, Inc. (NASDAQ: BNGO) and Ocugen, Inc. (NASDAQ: OCGN) were among the early movers among biopharma stocks. Bionano Gains On Adoption of Genomic Mapping System By U.... 
Via Benzinga
OCGN Stock: The Huge COVAXIN News Sending Ocugen Climbing Today
OCGN stock is gaining Wednesday morning on news that Bharat Biotech's COVAXIN has an overall 78% efficacy rate. Here's what to know. 
Via InvestorPlace
Exposures COVID-19
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Alterity Therapeutics (NASDAQ:ATHE) stock rose 23.16% to $1.54 during Wednesday's pre-market session. The company's market cap stands at $53.4 million.... 
Via Benzinga
Ocugen’s Outlook Is Still Very Bleak
The U.S. is likely to receive enough vaccines from its current partners, so OCGN stock will probably tumble over the longer term. 
Via InvestorPlace
Ocugen's Partner Bharat Biotech Ramping Manufacturing To Produce 700M COVID-19 Vaccine Doses Annually
India's Bharat Biotech has announced COVAXIN capacity expansion to support vaccination campaigns in India and globally amid increased COVID-19 infection cases. MoneyControl... 
Via Benzinga
Exposures COVID-19
Reddit Traders Can't Get Enough of These 2 Resurgent Biotech Stocks
New coronavirus projects make them easy to hype, but they could face strong headwinds soon. 
Via The Motley Fool
Exposures COVID-19
24 Stocks Moving in Monday's Pre-Market Session
Gainers InspireMD, Inc. (NYSE: NSPR) rose 29.3% to $0.53 in pre-market trading. InspireMD, last week, announced a 1-for-15 reverse split of its common stock effective April 26.... 
Via Benzinga
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
So what did the stock market do today? All eyes were on the Coinbase IPO, rallying copper stocks and the DISCB stock short squeeze. 
Via InvestorPlace
Topics Initial Public Offering Stocks
Exposures Securities Market US Equities
< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.